Literature DB >> 942770

Gamma hydroxybutyrate. Correlation of serum and cerebrospinal fluid levels with electroencephalographic and behavioral effects.

O C Snead, R K Yu, P R Huttenlocher.   

Abstract

Gamma hydroxybutyrate was administered to adult cats by intravenous infusion at varying dosages while an electroencephalogram (EEG) was recorded from electrodes placed stereotactically in the right and left hippocampus and thalamic intralaminar nucleus and from cortical electrodes. Blood cerebrospinal fluid samples were assayed for gamma hydroxybutyrate. The first EEG change, slowing was occasional spikes, was seen at serum levels of 75 mug per milliliter. Changes in the recordings progressed through a number of stages, culminating in bursts of poly spiking interspersed among periods of electrical silence first seen at 350 mug per milliliter. Behavior was characterized by a progressively deepening trancelike state punctuated at higher serum levels by spontaneous and stimulus-induced myoclonic jerks. These changes were correlated with serum levels and are more similar to petit mal stupor than any kind of natural sleep-like state previously used to describe them.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 942770     DOI: 10.1212/wnl.26.1.51

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

Review 1.  The role of GABAB mechanisms in animal models of absence seizures.

Authors:  S J Caddick; D A Hosford
Journal:  Mol Neurobiol       Date:  1996-08       Impact factor: 5.590

2.  Concentration-effect relationships for the drug of abuse gamma-hydroxybutyric acid.

Authors:  Melanie A Felmlee; Samuel A Roiko; Bridget L Morse; Marilyn E Morris
Journal:  J Pharmacol Exp Ther       Date:  2010-03-09       Impact factor: 4.030

3.  Positive cooperativity in high affinity binding sites for gamma-hydroxybutyric acid in rat brain.

Authors:  M Maitre; J F Rumigny; P Mandel
Journal:  Neurochem Res       Date:  1983-01       Impact factor: 3.996

4.  Comparison of N-methyl-2-pyrrolidone (NMP) and the "date rape" drug GHB: behavioral toxicology in the mouse model.

Authors:  Raffaella Arfè; Sabrine Bilel; Micaela Tirri; Paolo Frisoni; Giovanni Serpelloni; Margherita Neri; Federica Boccuto; Tatiana Bernardi; Federica Foti; Fabio De-Giorgio; Matteo Marti
Journal:  Psychopharmacology (Berl)       Date:  2021-04-21       Impact factor: 4.530

5.  Central and peripheral metabolic changes induced by gamma-hydroxybutyrate.

Authors:  Gianina Luca; Julie Vienne; Angélique Vaucher; Sonia Jimenez; Mehdi Tafti
Journal:  Sleep       Date:  2015-02-01       Impact factor: 5.849

6.  Pathway-specific action of gamma-hydroxybutyric acid in sensory thalamus and its relevance to absence seizures.

Authors:  Nicolas Gervasi; Zohreh Monnier; Pierre Vincent; Daniele Paupardin-Tritsch; Stuart W Hughes; Vincenzo Crunelli; Nathalie Leresche
Journal:  J Neurosci       Date:  2003-12-10       Impact factor: 6.167

7.  Effect of 3,4-methylenedioxymethamphetamine on the toxicokinetics and sedative effects of the drug of abuse, γ-hydroxybutyric acid.

Authors:  Nisha Vijay; Marilyn E Morris
Journal:  J Pharm Sci       Date:  2014-08-29       Impact factor: 3.534

8.  Effect of gammahydroxybutyric acid on serotonin synthesis, concentration and metabolism in the developing rat brain.

Authors:  T Hedner; P Lundborg
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

Review 9.  A critical evaluation of the gamma-hydroxybutyrate (GHB) model of absence seizures.

Authors:  Marcello Venzi; Giuseppe Di Giovanni; Vincenzo Crunelli
Journal:  CNS Neurosci Ther       Date:  2014-11-18       Impact factor: 5.243

10.  γ-Hydroxybutyric acid (GHB) is not an agonist of extrasynaptic GABAA receptors.

Authors:  William M Connelly; Adam C Errington; Vincenzo Crunelli
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.